Correction: BMC Health Serv Res 22, 1105 (2022)

https://doi.org/10.1186/s12913-022-08476-3

Following publication of the original article [1], the authors identified that a duplicated version of Fig. 1 was published as Fig. 2. The correct Fig. 2 is included in this Correction and the original article has been corrected.

Fig. 2
figure 1

Availability pattern of Prostate Cancer drugs in Private Hospital Vicinity. [ABIR: Abiraterone acetate; BICA: Bicalutamide; DOCE: Docetaxel; FLUT: Flutamide; GOSE: Goserelin; MITO: Mitoxantrone; OB: Originator brand; G: Generic; MG: Milligram]